Dostinex: Effective Prolactin Regulation Therapy
| Product dosage: 0.25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 32 | $3.60 | $115.08 (0%) | 🛒 Add to cart |
| 48 | $3.34 | $172.62 $160.51 (7%) | 🛒 Add to cart |
| 56 | $3.26
Best per pill | $201.39 $182.72 (9%) | 🛒 Add to cart |
| Product dosage: 0.5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 32 | $6.88 | $220.07 (0%) | 🛒 Add to cart |
| 48 | $6.60 | $330.10 $316.98 (4%) | 🛒 Add to cart |
| 56 | $6.53
Best per pill | $385.12 $365.44 (5%) | 🛒 Add to cart |
Synonyms | |||
Dostinex (cabergoline) is a prescription medication specifically formulated for the treatment of hyperprolactinemia, a condition characterized by abnormally high levels of the hormone prolactin. As a dopamine receptor agonist, it directly targets the pituitary gland to inhibit prolactin secretion, offering a targeted and efficient therapeutic approach. Its long half-life allows for convenient dosing, typically twice weekly, promoting patient adherence and consistent hormonal control. Clinically validated, it serves as a first-line treatment for both functional and tumor-induced hyperprolactinemia, addressing both biochemical abnormalities and associated symptoms.
Features
- Active ingredient: Cabergoline 0.5 mg per tablet
- Pharmacological class: Dopamine D2 receptor agonist
- Administration: Oral tablet
- Half-life: Approximately 63–69 hours
- Bioavailability: 40–50%
- Excretion: Primarily fecal (72%) and urinary (18–20%)
Benefits
- Effectively normalizes elevated prolactin levels, restoring endocrine balance
- Reduces or eliminates symptoms such as galactorrhea, infertility, and menstrual irregularities
- Shrinks prolactin-secreting pituitary adenomas, potentially avoiding surgical intervention
- Convenient twice-weekly dosing improves compliance and quality of life
- Demonstrates high efficacy with a favorable tolerability profile in clinical studies
- Supports restoration of gonadal function and fertility in affected individuals
Common use
Dostinex is primarily indicated for the treatment of hyperprolactinemia, regardless of etiology. This includes idiopathic hyperprolactinemia, microprolactinomas, and macroprolactinomas. It is used to manage symptoms such as galactorrhea, amenorrhea, oligomenorrhea, hypogonadism, and infertility in both women and men. Off-label, it may be utilized in the management of Parkinson’s disease due to its dopaminergic activity, though this is not its primary indication. Treatment is typically long-term, with regular monitoring of prolactin levels and pituitary imaging where applicable.
Dosage and direction
The initial recommended dosage is 0.5 mg per week, administered as 0.25 mg twice weekly (e.g., Tuesday and Friday). Dosage may be increased gradually by 0.5 mg per week at monthly intervals based on therapeutic response and prolactin levels, up to a maximum of 4.5 mg per week. Tablets should be taken orally with or without food. Dosage titration should be performed under strict medical supervision to minimize side effects. In patients with hepatic impairment, a lower starting dose and careful titration are advised.
Precautions
Patients should be monitored for signs of fibrotic reactions (e.g., pleural effusion, pulmonary fibrosis, retroperitoneal fibrosis), although these are rare with Dostinex at doses used for hyperprolactinemia. Caution is advised in patients with hypertension, particularly if uncontrolled. Echocardiographic monitoring is recommended in patients receiving long-term therapy, especially at higher doses, to assess for valvular regurgitation. Use with caution in patients with psychiatric disorders, as dopamine agonists may exacerbate conditions such as psychosis or impulse control disorders.
Contraindications
Dostinex is contraindicated in patients with hypersensitivity to cabergoline or any ergot derivatives. It should not be used in patients with uncontrolled hypertension, a history of cardiac valvulopathy, or fibrotic disorders. Concomitant use with other medications known to cause fibrotic reactions is contraindicated. It is also contraindicated in patients with severe hepatic impairment where dose adjustment cannot be adequately managed.
Possible side effects
Common side effects (>10%) include nausea, headache, and dizziness. Less frequently (1–10%), patients may experience fatigue, abdominal pain, constipation, vomiting, dyspepsia, or nasal congestion. Rare but serious adverse effects (<1%) include hypotension, syncope, pleural effusion, pulmonary fibrosis, and valvular heart disease. Psychiatric effects such as hallucinations, impulse control disorders, and pathological gambling have been reported, though infrequently at hyperprolactinemia treatment doses.
Drug interaction
Dostinex may interact with dopamine antagonists (e.g., antipsychotics like phenothiazines, butyrophenones) which can diminish its prolactin-lowering efficacy. Concomitant use with antihypertensive agents may potentiate hypotensive effects. Macrolide antibiotics (e.g., erythromycin) may increase cabergoline plasma concentrations. Use with other ergot derivatives is not recommended due to additive effects. Caution is advised when co-administering with medications that inhibit CYP3A4 enzymes.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling the dose to compensate for a missed dose is not recommended.
Overdose
Symptoms of overdose may include severe nausea, vomiting, hypotension, syncope, hallucinations, or nasal congestion. There is no specific antidote for cabergoline overdose. Management is supportive and symptomatic, including measures to maintain blood pressure and alleviate gastrointestinal distress. Gastric lavage or activated charcoal may be considered if ingestion was recent.
Storage
Store at room temperature (15–30°C or 59–86°F) in a dry place, protected from light and moisture. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or altering any medication regimen. Individual patient responses may vary, and therapeutic decisions should be based on clinical context and provider guidance.
Reviews
Clinical studies and post-marketing surveillance indicate high patient satisfaction with Dostinex, particularly regarding its efficacy in normalizing prolactin levels and resolving associated symptoms. Many users report significant improvement in quality of life, restoration of menstrual regularity, and successful pregnancy outcomes. The convenient dosing schedule is frequently cited as a positive factor aiding long-term adherence. Some users note initial side effects such as nausea or dizziness, which often diminish with continued use or dose adjustment.